… combination therapy with IN administration of NGF and EA facilitated cell proliferation and
survival, … The rationale for this combination treatment is that NGF and EA play different roles in …

… Hypoxic conditions provide optimal conditions for tumour growth and SFN modulates the
pathways involved in cell proliferation and survival. Specifically, SFN activates various anti-…

… influence growth and proliferation of the cancer cells in combination therapy. We treated the
… nine possible combinations of the two. Our data revealed that in most combination groups, …

… exists a problem of MSC survival at the graft. Experiments in … are known to influence cell
proliferation, motility, survival and … various growth factors on proliferation and survival in MSCs. …

… Proliferation is an important part of cancer development and progression. This is manifest …
which favors the survival and proliferation of cancer stem cells. Part of the survival strategy of …

… Our results suggest a new mechanism and reason for considering combination therapy with
retinoids. With this approach, scheduling of drug treatment would be important. With in vitro …

… Taken together, these data support our hypothesis that the 6-combination therapy plays a …
pathways important for inhibiting cancer cell migration, invasion, proliferation, and survival. …

… therapeutic agents studied to induce β-cell proliferation. Furthermore, we discuss possible
combination therapies of proliferation … and antioxidative therapy to improve overall long-term …

… For the lower dose of cisplatin analysed, that is 0.25 μm, significant decrease in cell
survival after combined therapy with respect to single treatments (42.8% CDDP 0.25 μm alone …

… to enhance therapeutic efficacy … combination therapy of FK778 with TAC in cell proliferation
assays in mice, nonhuman primates, and humans to determine whether combination therapy …